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Figure 1. Lifetime risk of THR and TKR for a person aged 40-49 years
stratiﬁed by gender.
Figure 2. Incidence of TKR and THR per 1000 according to healthcare
setting (2a), socio-economic status (2b) and geographic location (2c) from
1999/2000 to 2007/08.
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added to age, sex, BMI, WOMAC score and poor sleep quality (see
Figure 1).
Conclusions: Our data conﬁrm the strong difference in patient related
outcomes for THR and TKR and highlight the importance of under-
standing the factors that contribute to neuropathic pain like symptoms
and to pain in general post TKR.
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LIFETIME RISK OF TOTAL HIP AND KNEE REPLACEMENT AND
TEMPORAL TRENDS IN INCIDENCE BY HEALTH CARE SETTING,
SOCIOECONOMIC STATUS AND GEOGRAPHIC LOCATION
M. Bohensky y, I. Ackerman y, R. DeSteiger y, A. Gorelik z, C. Brand z.
yUniv. of Melbourne, Parkville, VIC, Australia; zMelbourne Hlth.,
Parkville, VIC, Australia
Purpose: Estimation of the lifetime risk of joint replacement surgery is
an emerging ﬁeld in musculoskeletal epidemiology. While global bur-
den of disease data are valuable for understanding disease incidence
and prevalence and the relative impact of a disease on patients’ lives(1),
lifetime risk provides an alternative method of quantifying population
disease burden and associated healthcare utilisation.(2) Gaining insight
into population-wide ﬂuctuations, which may be independent of dis-
ease burden, can be useful for budget priority setting and assessing the
impact of policy changes on healthcare utilisation. These data may also
support advocacy activities for policy and funding changes. Our primary
aim was to investigate lifetime risk of total hip (THR) and total knee
(TKR) replacement surgery. As changes in the lifetime risk of joint
replacement over time could be mediated by environmental, health
system or patient and clinician-level factors, we also sought to describe
temporal trends in incidence by relevant factors which may impact
utilisation of these procedures.
Methods: We analysed a population-based cohort of patients who
received a primary THR or TKR in Victoria, Australia from 1999 to 2008.
Hospital separations and life tables were used to estimate lifetime risk.
Temporal changes in THR and TKR incidence were examined according
to healthcare setting (public versus private), socio-economic status
(SES) and geographic location (regional versus metropolitan).
Results: We identiﬁed 45,775 patients receiving a primary THR and
43,570 receiving a primary TKR over the time period. The lifetime risk
by year for each procedure for a person aged 40-49 years is reported in
Figure 1. There was a greater increase in the lifetime risk of TKR when
compared to THR, particularly for females. We also identiﬁed an
increasing number of both procedures in private hospitals (increase in
THR of 0.14 per 1000 and TKR of 0.60 per 1000 over the time period), for
people in middle socio-economic groups (increase in THR of 0.11 per
1000 and TKR of 0.07 per 1000), low socio-economic groups (increase in
THR of 0.19 per 1000 and TKR of 0.10 per 1000) and in rural areas
(increase in THR of 0.24 per 1000 and TKR of 0.70 per 1000) (Figure 2).
The proportion of rural patients treated in private hospitals tended to be
signiﬁcantly less than patients in metropolitan settings (52.3% v 68.6%
for THR and 51.3% v 65.7% for TKR, p<0.01 for both). With the exception
of the increase in THRs in the middle socio-economic group, increases
were more pronounced for TKRs over the time period.
Conclusions: The larger increase in lifetime risk of TKR over the study
period could be partly attributed to the ageing population, with more
people aged over 80 receiving TKRs, increased rates of sporting inju-
ries(3) and rising rates of obesity (all risk factors for knee OA incidence
(4,5,6,7)). As the number of TKRs increased most in private hospitals, it
may also relate to insurance incentives introduced at the beginning of
the study period. Increases in the number of joint replacement proce-
dures performed for patients in regional areas suggest some reductions
over time in known disparities. The larger increase in incidence for
patients in regional areas could relate to greater previously unmet need,
a higher burden of OA in rural areas related to higher rates of obesity
and manual occupations and the increased provision of orthopaedic
services in rural areas over the past decade. The lifetime risk of THR
performed onwomenwas found to be similar to males, despite a higher
burden of hip OA. This difference may indicate under-utilisation of
surgery by females. Similarly, low SES was associated with an overall
lower incidence of THR and TKR during the study period. In Australia,
people with low SES generally have reduced access to the private hos-
pital system. This ﬁnding is consistent with studies from England and
Canada which have reported reduced utilisation of TKR by lower SES
groups.(8-10) These disparities warrant further investigation.References
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DO WOMEN HAVE POORER OUTCOMES FOLLOWING TOTAL KNEE
REPLACEMENT FOR OSTEOARTHRITIS?
S. Mehta y, M. Palaganas z, A.V. Perruccio x, A.M. Davis z. y Sch. of Physical
Therapy, Marshall Univ., Huntington, WV; zHlth.Care & Outcomes Res.,
Toronto Western Res. Inst., Univ. Hlth.Network, Toronto, ON, CANADA;
xArthritis Program, Div. of Orthopaedic Surgery, Toronto Western Hosp.,
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Purpose: Some prior research ﬁndings have suggested that females
have poorer outcomes following total knee replacement (TKR) than
males. Studies also have suggested that females with the same clinical
proﬁle as males are less likely to be offered hip or knee replacement.
Moreover, some studies report that females have worse pain and
functional status compared to males at the time of TKR. Given that pre-
surgery status remains the strongest predictor of outcome following
TKR, this study examined whether females were at risk of poorer pain
and functional outcomes at 6 and 12 months following TKR inde-
pendent of pre-surgery status.
Methods:This study utilized data from an existing cohort of 494
people who underwent primary TKR for osteoarthritis. The primary
outcomes of interest were the Pain and Function/Daily Activity sub-
scales of the Knee Injury and Osteoarthritis Outcome Score (KOOS)
(lower scores indicate worse status) at 6 and 12 months post-surgery.
In addition, the patient-completed survey captured age, sex, body
mass index (BMI), education level, presence of low back pain (LBP),
depression, number of comorbidities, and symptomatic joint count.
Descriptive statistics were calculated by sex for the personal and
health status characteristics and the KOOS. A sequential series of
regression analyses were conducted for each of the pain and function
Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56S16outcomes using the following independent variables: 1) sex; 2) sex
and age; 3) sex, age and pre-surgery score of the outcome; and, 4) the
latter model plus BMI, education level, low back pain (LBP), depres-
sion, number of comorbidities, and symptomatic joint count. P values
of  0.05 were considered signiﬁcant. As change between 6 and 12
months surgery is known to be much less relative to baseline to 6
months, we conducted analyses at 12 months as a validation of the 6
month results.
Results: The sample included 323 females and 171 males. Females had
worse pain and function scores at baseline compared to males (pain:
39.0  16.5 in females versus 44.9  16.4 in males, p¼0.002; function:
47.7  18.6 in females versus 55.0  17.5 in males, p<0.0001). As well,
females had worse pain and function at follow-up (72.218.4 vs. 76.1
17.7, p¼0.03; 75.2  17.5 vs 80.5  17.1, p¼0.003, respectively). Females
also had worse pre-surgery depression scores (5.6  3.6 vs 4.7  3.2,
p¼0.006), higher rates of obesity (BMI >30: 54.2 vs. 36.3%, p¼0.0002),
and higher symptomatic joint count (>4: 61.3 vs. 44.4%, p¼0.0004).
Initially, regression ﬁndings suggested that females had worse out-
comes for pain (p¼0.04) and function (p¼0.007) compared to males.
However, this effect was lost once baseline pain/functional status were
also considered. In the ﬁnal model, worse outcomes were predicted by
pre-surgery pain/functional status, as well as depression, LBP and
comorbidity count. The results at 12months were consistent with those
at 6 months.
Conclusions: Women appear to have worse outcomes following TKR in
part as a function of their greater pain and more limited function pre-
surgery. However, depression and comorbidity, for which women have
worse status pre-surgery, further contribute to worse outcomes. These
ﬁnding suggest that women potentially could achieve comparable
outcomes tomen if surgery were performed before their symptoms and
disability became so severe. This could, in addition, limit the effect of
mood or, alternately, interventions to address mood could positively
inﬂuence outcomes.
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IDENTIFICATION OF SEROLOGICAL PROFILES ASSOCIATED WITH
TOTAL JOINT REPLACEMENT IN OSTEOARTHRITIS PATIENTS
R.H. Arends y, M.A. Karsdal z, A.C. Bay-Jensen z, D.S. Keller y. y Pﬁzer,
Groton, CT, USA; zNordic BioSci., Herlev, Denmark
Purpose: 1. To identify patients who will progress to requiring total
joint replacement (TJR) amongst a populationwith moderate-to severe-
osteoarthritis (OA) by measuring tissue speciﬁc biomarkers in serum
thus establishing a panel of prognostic biomarkers that may provide
molecular insight into the mechanism and pathology of the progression
of OA. 2. Investigate the effect of NSAIDs on the predictive and diag-
nostic serum proﬁle.
Methods: OA patients were randomly selected from clinical trials
investigating the anti-NGF therapeutic antibody tanezumab. Serum
samples from 240 patients who underwent a TJR (cases) and from 440
control OA patients who did not undergo TJR were used. Control group
consisted of w2 patients per case matched on: age (<65 or  65
years), Kellgren-Lawrence (K-L) grade, gender, BMI category (<30 or
30 kg/m2), OA severity (severe if both WOMAC Pain and Physical
function subscale scores were 7 and the Patient Global Assessment
score was 4 (i.e. Poor or Very Poor), otherwise baseline OA severity
was classiﬁed as not severe). On the average, the OA population was 62
years old, 80% K-L grade 3, females (68%), BMI w31 kg/m2, WOMAC
pain score of 7. Serum samples were analyzed for bone (Total Osteo-
calcin, CTX-I, DKK1, SOST), cartilage (C2M, COMP, PIIANP), connective
tissue (PINP, ICTP, C1M), synovial tissue (C3M), protease burden (MMP-
9) as well as inﬂammation markers (IL6, hsCRP, VEGF). Classiﬁcation
and Regression Tree analysis was used to identify biomarker
phenotypes.
Results: For NSAID and non-NSAID users separately, biomarker phe-
notypes were identiﬁed at baseline for patients predisposed for TJR. At
baseline, a biomarker combination for patients who used NSAIDs before
start of tanezumab clinical trials identiﬁed 96% of patients who
underwent a TJR and 61% of the patients who did not undergo a TJR.
Identiﬁcation of these biomarker phenotypes lowers the odds of a TJR
by 14-fold as compared to not having knowledge of the biomarkers. For
patients who did not use NSAIDs, 83% of patients who had a TJR and 63%
of the patients who did not undergo a TJR, were identiﬁed which lowers
the odds of a TJR by 3.6-fold. For patients who used NSAIDs con-
tinuously, 84% of patients who had a TJR and 77% of the patients whodid not have a TJR, were identiﬁed which lowers the odds of a TJR by
4.7-fold.
Conclusions: Serological biomarker proﬁles for predicting TJR were
identiﬁed irrespective of NSAID use and may assist in identifying
those patients whom will need a TJR. The proﬁles also suggest that
NSAID use increases the importance of the role of bone metabolism
in TJR pathology. The results need validation on other cohorts, and
may ﬁnally provide value to patients and payers in selecting the
most optimal treatment strategy for moderate-to-severe OA
patients.
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MALES ARE AT INCREASED RISK FOR SURGICAL COMPLICATIONS
FOLLOWING TOTAL JOINT ARTHOPLASTY
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Toronto, Toronto, ON, Canada; z Inst. for Clinical Evaluative Sci. (ICES),
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Purpose: The burden of osteoarthritis of the hip and knee is higher
in females than in males. Despite this, there remains a gender dis-
parity in the recommendation and uptake of total joint arthroplasty
(TJA), with males being more likely to be offered surgery. This may
result from a perception that females have a higher rate of compli-
cations, including: acute myocardial infarction (AMI), venous
thrombo-embolism (VTE), infection, dislocation, early revision, and
death. To date, few studies have examined if differences by sex
persist in the rates of complications following TJA of the hip (THA) or
knee (TKA).
Methods: We deﬁned a cohort of patients who received their ﬁrst
primary elective THA or TKA between 2002-2009 utilizing admin-
istrative databases from Ontario, Canada. We excluded those who
received a primary or revision arthroplasty of the hip or knee prior to
April 1, 2002, those whose ﬁrst procedure was non-elective (e.g. for
cancer, fracture, or injury), or those with a history of hip dysplasia. We
compared baseline characteristics and rates of complications follow-
ing the index TJA for male and female recipients. Cox proportional
hazards were used to determine the relationship between sex and the
occurrence of speciﬁc complications (within 90d: VTE, AMI, mortality;
within 2y: dislocation, infection, and revision), deﬁned using vali-
dated algorithms, controlling for potential confounders (including
income quintile, rurality, and provider volume) and for clustering by
surgeons.
Results: Between April 1, 2002 and March 31, 2009, there were 97,445
patients who received their ﬁrst TJA (males: 41,023 - 42%; females:
56,422 - 58%). Compared with female TJA recipients, males were more
likely to have received a THA (43% versus 36%, p<0.001), more likely to
come from a rural area (20% versus 15%, p<0.001), and had greater co-
morbidity (Charlson score of 2þ: 5.5% vs 3.5%, p<0.001). Controlling for
these differences, and other potential confounders, male TJA recipients
were more likely to experience an infection (adjusted HR 1.41, 95%CI
1.24-1.61, p<0.0001), early revision (adjusted HR 1.24, 95%CI 1.10-1.40,
p¼0.0006), or death (adjusted HR 1.26, 95%CI 1.03-1.55, p¼0.03). They
were similarly likely to experience all other complications: dislocation
(adjusted HR 0.94, 95%CI 0.79-1.12, p¼0.48), AMI (adjusted HR 1.05, 95%
CI 0.93-1.19, p¼0.41), and VTE (adjusted HR 0.99, 95%CI 0.88-1.12,
p¼0.95).
Conclusions: In a population cohort undergoing their ﬁrst primary TJA,
male recipients were at increased risk for early revision, infection and
death relative to female recipients.
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BMP2 REQUIRES TGF-BETA TO INDUCE OSTEOPHYTES DURING
EXPERIMENTAL OA
E.N. Blaney Davidson, E.L. Vitters, A.B. Blom, A.P. van Caam,
M.B. Bennink, W.B. van den Berg, F.A. van de Loo, P.M. van der Kraan.
Radboud Univ. Med. Ctr., Nijmegen, Netherlands
Purpose: Osteophyte formation is one of the hallmarks of osteo-
arthritis (OA). We have shown that either overexpression of TGF-beta
or BMP2 can induce osteophytes in murine knee joints. However,
comparing osteophytes induced by experimental OA, TGF-beta or
BMP2 showed us that TGF-beta-induced osteophytes rather than
BMP2-induced osteophytes more closely resemble those observed in
experimental OA. TGF-beta-induced osteophytes develop mainly from
